For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230112:nRSL5124Ma&default-theme=true
RNS Number : 5124M R&Q Insurance Holdings Ltd 12 January 2023
R&Q Insurance Holdings Ltd
("R&Q" or the "Company")
PDMR/Director Shareholding and Total Voting Rights
R&Q announces that the 5,178,524 restricted ordinary shares of 2p each
("Ordinary Shares") awarded to William Spiegel in January 2020 in accordance
with his renumeration package, together with 235,387 Ordinary Shares, issued
as part of the Company's bonus share distribution of 1 share for every 22 held
in July 2020, vested on 10 January 2023. To fund tax liabilities arising from
the vesting William Spiegel has sold 2,822,371 Ordinary Shares which, in
accordance with the share award agreement, have been purchased by the Company
to be held in Treasury.
Director Dealing
Name of Director Total Restricted Ordinary Shares Vested Total Ordinary Shares Sold Total Ordinary Shares Retained Total R&Q Ordinary Shares now held % of voting rights
William Spiegel 5,413,911 2,822,371 2,591,540 2,746,207 0.73%
Total Voting Rights
As a result of this transaction the total issued share capital will remain
377,395,235 Ordinary Shares. Of which 2,822,371 Ordinary Shares are now held
in Treasury. Therefore, the total number of voting rights will be 374,572,864
and may be used by Shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Enquiries to:
R&Q Insurance Holdings Ltd
William Spiegel Tel: 0207 780 5850
Tom Solomon Tel: 0207 780 5850
Numis Securities Limited (Nominated Advisor and Joint Broker)
Giles Rolls Tel: 020 7260 1000
Charles Farquhar Tel: 020 7260 1000
Barclays Bank PLC (Joint Broker)
Andrew Tusa Tel: 020 7632 2322
Richard Bassingthwaighte
FTI Consulting
Tom Blackwell Tel: 020 3727 1051
Notes to Editors:
About R&Q
R&Q is a global non-life specialty insurance company. We operate two core,
highly complementary, businesses: Program Management and Legacy Insurance.
Both these businesses are leaders in their respective markets.
Our approach is to deploy our origination and underwriting capabilities,
alongside our licensed and rated carriers in the US, EU and the UK, to
generate attractive fee returns in Program Management and Legacy Insurance.
Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94
Website: www.rqih.com (http://www.rqih.com)
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibility / person closely
associated
a) Name William Spiegel
2 Reason for the notification
a) Position/status PDMR (Executive Director)
b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name R&Q Insurance Holdings Ltd
b) LEI 2138006K1U38QCGLFC94
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 2 pence each of the Company
Identification code Ordinary share ISIN: BMG7371X1065
1. Vesting of 5,413,911 restricted ordinary shares
b) Nature of transaction 2.Sale of 2,822,371 ordinary shares
c) Price(s) and volume(s) Price(s) Volume(s)
1 Nil 5,413,911 Ordinary Shares nil consideration
2 £0.678 Sale of 2,822,371 shares for a total consideration of £1,913,567.24
d) Aggregated information
As above
Aggregated volume
Price As above
e) Date of transaction 10 January 2023
f) Place of transaction Outside of trading location
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHEAKFAFAXDEEA